Visitors, including guests, contractors and vendors, to any MCW campus are asked to refrain from coming to campus. Badge-access is required to enter any campus building. All MCW-sponsored site visits or gatherings of more than 10 individuals are cancelled and/or must be rescheduled for a later date. For MCW updates on the COVID-19 pandemic, visit covid19.mcw.edu.
Learn More
Learn More
SPARCC is recruiting underrepresented minority undergraduate students for an 8-week, intensive summer research program focused on developing a career in clinical cancer prevention, treatment and care.
Learn More
Learn about making a gift
The Department of OBGYN together with our institution are actively taking measures to address structural racism and the resulting health inequities. The current disparities in obstetric and other health outcomes among women of color are extremely disturbing. We are committed to improving outcomes and eliminating the healthcare disparities that exist within our community.
We pledge and are working to diversify our workforce while providing the resources and mentorship to ensure success. We are actively developing programs in which learners and employees will thrive in a diverse, equitable, inclusive and safe environment. We expect all who work here to self-reflect, acknowledge and speak out against any bias, discrimination or racism.
"The Word on Medicine” recorded our program on Cervical Cancer: medical experts and patients discuss the symptoms and treatment of cervical dysplasia and cervical cancer; the role of human papillomarivus (HPV); and current strategies in treatment for cervical cancer as well as new therapies on...
U.S. News & World Report today published the inaugural edition of the Best Hospitals for Maternity, which expands the U.S. News Best Hospitals rankings, ratings and data offerings. Our Maternal Fetal Care Center was rated "High Performing in Maternity Care (Uncomplicated Pregnancy)"....
Research from the Chaluvally Lab identified a protein that targets and amplifies the impact of the cMYC oncogene – a gene either mutated or overexpressed in a significant number of tumor tissues in patients with ovarian cancer. ...
Dr. Kimberly Gecsi joined the Department of Obstetrics and Gynecology in August 2021 in the Division of General Obstetrics and Gynecology. ...
We are pleased to announce that Kristina Kaljo, PhD, has been named the "Faculty Pillar Director" in the Robert D. and Patricia E. Kern Institute for the Transformation of Medical Education (Kern Institute)....
Leadership Education to Advance Diversity in Underrepresented Populations (LEAD-UP) is a new leadership enrichment program for URiM trainees situated in the last two years of their program: residents, fellows, post-docs, and MD/PhD students. ...
Women looking to get pregnant in the next year should absolutely get the COVID-19 vaccine, says Dr. Jennifer McIntosh, Maternal-Fetal Medicine provider of Froedtert and the Medical College of Wisconsin....
In the 5-year follow-up of the pivotal SOLO-1 trial in women with advanced ovarian cancer and a BRCA1/2 mutation, maintenance treatment with olaparib led to a doubling in progression-free survival. William H. Bradley, MD, presented these findings at the Society of Gynecologic Oncology (SGO) 2021...
It is our pleasure to announce that the Department of Obstetrics & Gynecology (OB/GYN) has successfully completed a search for a new Department Administrator....
